Breaking News Instant updates and real-time market news.

ESRX

Express Scripts

$70.34

0.43 (0.62%)

16:55
10/05/16
10/05
16:55
10/05/16
16:55

Express Scripts initiated with a Neutral at UBS

Target $76.

  • 26

    Oct

  • 06

    Nov

ESRX Express Scripts
$70.34

0.43 (0.62%)

08/02/16
BMOC
08/02/16
NO CHANGE
BMOC
Outperform
Horizon Pharma scored 'important win' with CVS, says BMO Capital
BMO Capital analyst Gary Nachman said Horizon Pharma (HZNP) securing covered status for Duexis and Vimovo with CVS/Caremark (CVS) is an "important win" for the drugmaker that demonstrates it is improving its execution on the managed care front. While Express Scripts (ESRX) still has Duexis and Vimovo on its exclusion list for 2017, Horizon indicated that it is still in discussions that have been "constructive," noted Nachman, who keeps an Outperform rating on Horizon shares.
08/09/16
LEER
08/09/16
NO CHANGE
Target $110
LEER
Outperform
Leerink remains positive on CVS Health long-term fundamentals
Leerink analyst David Larsen continues to be positive on CVS' (CVS) long-term fundamentals. The analyst notes that the company is having a successful 2017 selling season, with a retention rate higher than what it was last year, and says its Q3 should benefit from a number of break-even generics. Further, Larsen says the company is being more aggressive than Express Scripts (ESRX) with regards to formulary management, and believes that if CVS provides a 5-year outlook in December, shares will likely rally. Larsen reiterates an Outperform rating and $110 rating on CVS' shares.
08/15/16
LEER
08/15/16
NO CHANGE
LEER
Outperform
Leerink more positive on CVS after Formulary exclusions lists
Leerink analyst David Larsen says he's incrementally more positive on CVS Health (CVS) after the company and Express Scripts (ESRX) published their 2017 National Preferred Formulary exclusions lists. CVS is being more aggressive about using bio-similar products and has excluded about 10 products due to hyperinflation trends, Larsen tells investors in a research note. Express Scripts is excluding around 85 products in 2017, which is almost half of the 153 products being excluded by CVS, the analyst writes. He keeps an Outperform rating on CVS and a Market Perform ration on Express Scripts.
08/29/16
LEER
08/29/16
NO CHANGE
LEER
EpiPen price is Mylan's issue, says Leerink
Leerink analyst David Larsen says the recent weakness in pharmacy benefit managers and the drug distribution group is "overdone," as he believes Mylan (MYL) has been taking the vast majority of the pricing increases that have occurred with EpiPen, not the pharmacy benefit managers and distributors. Further, the analyst estimates that Cardinal Health (CAH) has a "fee-for-service" deal with EpiPen, which means that there may be no benefit to the company for any price increase that occurs, and notes that Express Scripts (ESRX) gives back 80%-90% of EpiPen rebates to their plan customers. Larsen would be a buyer of CVS Health (CVS) on weakness.

TODAY'S FREE FLY STORIES

FB

Facebook

$133.72

0.19 (0.14%)

11:06
02/22/17
02/22
11:06
02/22/17
11:06
Hot Stocks
Instagram announces update allowing sharing of multiple photos in one post »

Facebook's Instagram…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 28

    Feb

  • 06

    Mar

  • 19

    Mar

  • 28

    Mar

WMAR

West Marine

$9.15

-0.01 (-0.11%)

11:06
02/22/17
02/22
11:06
02/22/17
11:06
Conference/Events
West Marine management to meet with B. Riley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 28

    Feb

AAP

Advance Auto Parts

$157.00

-4.155 (-2.58%)

11:06
02/22/17
02/22
11:06
02/22/17
11:06
Options
Advance Auto Parts call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMTD

TD Ameritrade

$43.28

0.13 (0.30%)

11:05
02/22/17
02/22
11:05
02/22/17
11:05
Conference/Events
TD Ameritrade management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

AMD

AMD

$14.00

0.87 (6.63%)

11:04
02/22/17
02/22
11:04
02/22/17
11:04
Conference/Events
AMD management to meet with Canaccord »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

MOBL

MobileIron

$4.90

0.15 (3.16%)

11:04
02/22/17
02/22
11:04
02/22/17
11:04
Hot Stocks
MobileIron forms Internet of Things division »

MobileIron announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

MOBL

MobileIron

$4.90

0.15 (3.16%)

11:04
02/22/17
02/22
11:04
02/22/17
11:04
Hot Stocks
MobileIron forms Internet of Things division »

MobileIron announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

AMD

AMD

$14.00

0.87 (6.63%)

11:04
02/22/17
02/22
11:04
02/22/17
11:04
Technical Analysis
AMD ticks fresh multi-year and 52-week high »

The shares were last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

MRVL

Marvell

$16.21

0.4 (2.53%)

11:04
02/22/17
02/22
11:04
02/22/17
11:04
Conference/Events
Marvell management to meet with B. Riley »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 10

    Mar

  • 04

    Apr

  • 05

    Apr

SQ

Square

$14.70

0.07 (0.48%)

, AAPL

Apple

$136.70

0.98 (0.72%)

11:02
02/22/17
02/22
11:02
02/22/17
11:02
Earnings
On The Fly: What to watch in Square earnings report »

Square (SQ) is scheduled…

SQ

Square

$14.70

0.07 (0.48%)

AAPL

Apple

$136.70

0.98 (0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 13

    Mar

CWBC

Community West Bancshares

$10.13

0.0252 (0.25%)

11:02
02/22/17
02/22
11:02
02/22/17
11:02
Hot Stocks
Community West Bancshares says CFO Baltuskonis to retire July 2017 »

Community West Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFL

Aflac

$71.36

-0.06 (-0.08%)

11:02
02/22/17
02/22
11:02
02/22/17
11:02
Conference/Events
Aflac management to meet with Sandler O'Neill »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 05

    Mar

ARGS

Argos Therapeutics

$4.40

-0.3 (-6.38%)

10:56
02/22/17
02/22
10:56
02/22/17
10:56
Downgrade
Argos Therapeutics rating change  »

Argos Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 27

    Apr

CPB

Campbell Soup

$59.42

0.47 (0.80%)

10:56
02/22/17
02/22
10:56
02/22/17
10:56
Hot Stocks
Campbell Soup CEO repeats plan to achieve $300M in cost savings by end of FY17 »

Campbell Soup CEO Denise…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

TSO

Tesoro

$88.39

-0.69 (-0.77%)

10:56
02/22/17
02/22
10:56
02/22/17
10:56
Options
Tesoro put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$14.00

0.87 (6.63%)

, INTC

Intel

$36.52

0.04 (0.11%)

10:53
02/22/17
02/22
10:53
02/22/17
10:53
Periodicals
AMD looks to challenge Intel's PC processor dominance, FT says »

With a new type of…

AMD

AMD

$14.00

0.87 (6.63%)

INTC

Intel

$36.52

0.04 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    Feb

  • 27

    Feb

  • 19

    Mar

  • 04

    Apr

  • 05

    Apr

CEO

CNOOC

$121.51

-1.14 (-0.93%)

10:52
02/22/17
02/22
10:52
02/22/17
10:52
Recommendations
CNOOC analyst commentary  »

CNOOC named a long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QVCA

Liberty Interactive

$19.71

0.41 (2.12%)

10:51
02/22/17
02/22
10:51
02/22/17
10:51
Technical Analysis
Liberty Interactive spikes higher on very heavy volume »

The stock has spiked,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAA

Under Armour

$22.25

0.47 (2.16%)

10:48
02/22/17
02/22
10:48
02/22/17
10:48
Options
Under Armour calls active as shares tick higher »

Under Armour calls active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EAT

Brinker

$42.55

-1.32 (-3.01%)

10:45
02/22/17
02/22
10:45
02/22/17
10:45
Conference/Events
Brinker management to meet with Maxim »

Field trip to company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 03

    May

KR

Kroger

$33.05

-1.175 (-3.43%)

10:41
02/22/17
02/22
10:41
02/22/17
10:41
Options
Pre-earnings jitters in Kroger as shares slide »

Pre-earnings jitters in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNP

Union Pacific

$108.18

-1.495 (-1.36%)

10:39
02/22/17
02/22
10:39
02/22/17
10:39
Hot Stocks
Breaking Hot Stocks news story on Union Pacific »

Union Pacific says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 09

    May

ECPG

Encore Capital

10:38
02/22/17
02/22
10:38
02/22/17
10:38
Periodicals
Cabot Credit considering London stock listing, Sky News reports »

Shareholders in Cabot…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

UNP

Union Pacific

$108.18

-1.49 (-1.36%)

10:38
02/22/17
02/22
10:38
02/22/17
10:38
Hot Stocks
Breaking Hot Stocks news story on Union Pacific »

Union Pacific says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 09

    May

UNP

Union Pacific

$108.18

-1.49 (-1.36%)

10:35
02/22/17
02/22
10:35
02/22/17
10:35
Hot Stocks
Union Pacific sees coal market more stable going forward »

Comment from Barclays…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 09

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.